This study is not yet accepting patients
Predicting Inflammatory Skin Disease Response to IL-23 Blockade
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California
- Dates
- study startedestimated completion
- Principal Investigator
- by Raymond Cho, MD, PhD
Description
Summary
Details
Keywords
Eligibility
Location
Lead Scientist at UCSF
- Raymond Cho, MD, PhD
Dr. Cho investigates the molecular basis of skin disease. He currently develops single-cell molecular fingerprints of unusual skin diseases to identify effective immunomodulatory therapies, in collaboration with the laboratory of Dr. Jeffrey Cheng.
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Francisco
- ID
- NCT04541329
- Phase
- Phase 4
- Study Type
- Interventional
- Last Updated